Team

Team

Jeff Klunzinger
Jeff Klunzinger
Co-Founder and General Partner

Jeff Klunzinger

Co-Founder and General Partner

Jeff guides strategic investments and coordinates operations for OS Fund’s team of researchers and associates. He also supports the Fund’s portfolio companies with strategy, execution, partnership and operational expertise.

See More

Bryan Johnson
Bryan Johnson
Co-Founder and General Partner

Bryan Johnson

Co-Founder and General Partner

In 2014, Bryan invested $100M to start OS Fund, which invests in scientist entrepreneurs predictably engineering atoms, molecules, organisms and complex systems.

See More

Dr. Lily Kim
Dr. Lily Kim
Partner, Chief Scientist

Dr. Lily Kim

Partner, Chief Scientist

Lily is an expert in early-stage life sciences commercialization. She attended both Harvard and MIT and concentrated in Electrical and Biomedical Engineering. Prior to OS Fund she was part of the business development team at the Wyss Institute.

See More

Dr. Omar Ali
Dr. Omar Ali
Venture Partner

Dr. Omar Ali

Venture Partner

Omar advises in the areas of Biomaterials, Immunotherapy, Materials Science and Drug Delivery. He received his PhD from Harvard University in Engineering and Applied Sciences with a focus in Bioengineering.

See More

Josh Elkington
Josh Elkington
Venture Partner

Josh Elkington

Venture Partner

Josh attended Harvard University where he studied molecular biology and worked under Gary Ruvkun, with graduate training at UC Berkeley in biochemistry under Jennifer Doudna and Robert Tjian.

See More

Gina Gauthier
Gina Gauthier
Chief of Staff

Gina Gauthier

Chief of Staff

Gina manages administrative, PMO, benefits/payroll, social media marketing, and special event functions for OS Fund, as well as provides support to the firm’s co-Founders.

See More

Mark Ghobrial
Mark Ghobrial
Partner

Mark Ghobrial

Partner

Mark has been a part of the investment team since the founding of OS Fund. In his time at OS Fund he has focused on diligence and sourcing of deals across Genomics, Synthetic Biology, and Advanced Materials.

See More

Daniel Robinson
Daniel Robinson
Partner

Daniel Robinson

Partner

Dan focuses on the sourcing and diligence of investments across synthetic and computational biology, advanced materials, robotic systems, and nextgen compute, and provides strategic support to portfolio companies.

See More

Dr. Tariq Warsi
Dr. Tariq Warsi
Venture Partner

Dr. Tariq Warsi

Venture Partner

Tariq advises in the areas of Synthetic Biology and Genome Editing. He received his PhD from University of California, Riverside in Cell and Molecular Biology, after which he served as a Postdoctoral Fellow at Harvard Medical School.

See More

Jonathan Yaffe
Jonathan Yaffe
Chief Financial Officer

Jonathan Yaffe

Chief Financial Officer

Jonathan joined the firm in 2019 and serves the team in areas of finance, investor relations, operations, compliance, marketing, and strategy. Jonathan obtained his BBA with a major in accounting from the University of Wisconsin - Madison.

See More